Based on pilot patient observations,the investigators anticipate that chronic fatigue
syndrome (CFS) patients may benefit from B-cell depletion therapy.
The hypothesis is that at least a subset of CFS patients have an activated immune system
involving B-lymphocytes, and that B-cell depletion may alleviate symptoms.